“copyright treatment would incorporate enormous prices on the procedure procedure whilst furnishing only a little, distinct benefit — and so cause a huge misallocation of by now extremely scarce assets.”The marketing campaign was prompted in part by a professional panel’s frustrating rejection in June of Lykos’s application, on account of